Evidence map›Paper›PMID 40496716›Full record

ArticleDigital health

Conception and usability pilot study of a new digital cognitive screening tool on tablet: AlzVR project.

Florian Maronnat, Guillaume Loup, Jonathan Degand, Frederic Davesne, Samir Otmane

Abstract read
In one paragraph

Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Florian MaronnatUniv Évry, IBISC, Université Paris-Saclay, Évry-Courcouronnes, France.ORCID https://orcid.org/0000-0003-3766-5789
Guillaume LoupUniv Évry, IBISC, Université Paris-Saclay, Évry-Courcouronnes, France.ORCID https://orcid.org/0000-0003-3476-583X
Jonathan DegandUniv Évry, IBISC, Université Paris-Saclay, Évry-Courcouronnes, France.
Frederic DavesneUniv Évry, IBISC, Université Paris-Saclay, Évry-Courcouronnes, France.ORCID https://orcid.org/0000-0001-9100-7109
Samir OtmaneUniv Évry, IBISC, Université Paris-Saclay, Évry-Courcouronnes, France.ORCID https://orcid.org/0000-0003-2221-4264

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Alzheimer's disease (AD) is the first cause of dementia worldwide without any current curative treatment. Facing an increasing prevalence and its associated costs, AD represents a public health challenge. Usual diagnostic methods still rely on extended interviews and paper tests provided by an exterior examiner. We aim to create a novel, quick cognitive-screening tool on a numerical tablet. Methods: This pilot program, built and edited with Unity Results: Twenty-four participants were included with a final F-SUS 'excellent' score. Participants perceived the tool as simple to use and achieved the test in a mean time of 142 s. No technical errors occurred. Conclusion: These preliminary results suggest that our new assessment on a numerical tablet might be usable and acceptable for a short cognitive screening but requires further studies among older populations.

Indexed as

Alzheimer's diseaseNumerical tabletprimary carescreeningusability

Identifiers

PMID40496716
PMCPMC12149633

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.